From: Personalized medicine in Europe: not yet personal enough?
Benefits | Experts |
---|---|
Avoiding side effects/optimize side effect profile | Academics (3), clinical experts (2), economic experts (3), EFPIA representative (1), patient representatives (2) |
Avoiding waste of resources/over-treating/selecting only patients who need it | Academic (1), clinical experts (2), economic experts (3), EFPIA representative (1), patient representatives (2), payer (1) |
Improved outcomes in terms of effectiveness/efficacy | Academic (1), clinical expert (1), economic experts (3), patient representative (1), payer (1) |
Better outcome/benefit/response rate (not specified) | Academic (1), clinical experts (2), economic experts (2), provider (1) |
Improved cost-effectiveness/value for money | Clinical expert (1), economic experts (3), payer (1) |
Reduce costs | Economic experts (3), payer (1) |
Improved length of life | Academic (1), clinical expert (1), economic expert (1) |
Improved quality of life | Academic (1), economic expert (1) |
Free-up time from clinicians | Patient representative (1), payer (1) |